Disagree. Clinical factors you mention re: Safety are all Phase 1 protocols
You would expect them to all be ok given we are about to go to P2B
Nothing until late May
Today's volume is also telling you the same story - only 1m traded. Only retail nuff nuffs buying, not the HNW's or Insto's backed by the brokerage houses that have valuations on it
Ann: US FDA Type C Meeting for ATL1102 in DMD, page-29
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
